Open access
Open access
Powered by Google Translator Translator

Covid-19

Massive Google-funded COVID database will track variants and immunity

25 Feb, 2021 | 09:03h | UTC

Massive Google-funded COVID database will track variants and immunity – Nature

See also: Backed by Google, epidemiologists launch a sweeping Covid-19 data platform – STAT

 


Why COVID vaccines are so difficult to compare

25 Feb, 2021 | 09:02h | UTC

Why COVID vaccines are so difficult to compare – Nature

 


Opinion: Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity

25 Feb, 2021 | 08:57h | UTC

Importance of non-pharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity – The Lancet Infectious Diseases

 

Commentary on Twitter

 


Perspective: Coronavirus reinfection will soon become our reality

25 Feb, 2021 | 08:59h | UTC

Coronavirus reinfection will soon become our reality – The Atlantic (a few articles per month are free)

 


Why are COVID-19 case numbers dropping?

24 Feb, 2021 | 02:59h | UTC

Why Are COVID-19 Case Numbers Dropping? – HIV and ID Observations

 


Study: Patients with severe COVID-19 might shed viable virus during prolonged periods of up to 4 weeks

24 Feb, 2021 | 02:56h | UTC

Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19 – Clinical Microbiology and Infection

 

Commentary on Twitter

 


We’re Just Rediscovering a 19th-Century Pandemic Strategy (Ventilation)

24 Feb, 2021 | 02:58h | UTC

We’re Just Rediscovering a 19th-Century Pandemic Strategy – The Atlantic

 


Schools may see a burst of the common cold when they reopen, research suggests

24 Feb, 2021 | 02:51h | UTC

Schools may see a burst of the common cold when they reopen, research suggests – STAT

 


How the COVID-19 pandemic will change the future of critical care

24 Feb, 2021 | 02:49h | UTC

How the COVID-19 pandemic will change the future of critical care – Intensive Care Medicine

 

Commentary on Twitter

 


Educators may be more central drivers of Covid-19 in schools than students, CDC study finds

24 Feb, 2021 | 02:55h | UTC

Educators may be more central drivers of Covid-19 in schools than students, CDC study finds – CNN

Original study: Clusters of SARS-CoV-2 Infection Among Elementary School Educators and Students in One School District — Georgia, December 2020–January 2021 – CDC Morbidity and Mortality Weekly Report

 

Commentary on Twitter

 


Perspective: Is one vaccine dose enough after COVID-19 infection?

24 Feb, 2021 | 02:47h | UTC

Is One Vaccine Dose Enough After COVID-19 Infection? – NIH Director’s Blog

Related: France’s health authority recommends single vaccine shot for people who have had COVID-19

 


Musculoskeletal involvement of COVID-19: review of imaging

24 Feb, 2021 | 02:43h | UTC

Musculoskeletal involvement of COVID-19: review of imaging – Skeletal Radiology

Commentaries: Radiological images confirm ‘COVID-19 can cause the body to attack itself’ – Northwestern University AND Imaging highlights COVID-19’s MSK manifestations – AuntMinnie

 


The growing evidence that the Covid-19 vaccines can reduce transmission, explained

24 Feb, 2021 | 02:40h | UTC

The growing evidence that the Covid-19 vaccines can reduce transmission, explained – Vox

Related: Can COVID vaccines stop transmission? Scientists race to find answers – Nature AND Fauci: There’s evidence COVID-19 vaccines don’t just protect you — they may stop you from spreading the virus to others, too – Insider AND [Preprint] Covid-19 vaccination associated with reduced viral load, may reduce transmission (study and commentary)

 


Podcast: Vaccinating Individuals with Prior COVID-19

23 Feb, 2021 | 01:53h | UTC

Vaccinating Individuals with Prior COVID-19 – Infectious Diseases Society of America

 

Commentary on Twitter

 


FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias

23 Feb, 2021 | 02:03h | UTC

FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias – STAT

FDA Safety Alert: Pulse Oximeter Accuracy and Limitations: FDA Safety Communication – U.S. Food & Drug Administration

Related: “Racial Bias in Pulse Oximetry Measurement”. In two large cohorts, Black patients had nearly three times the frequency of occult hypoxemia that was not detected by pulse oximetry as White patients – New England Journal of Medicine (study and commentaries)

 


FDA: No credible evidence of food or food packaging associated with viral transmission of SARS-CoV-2

23 Feb, 2021 | 02:05h | UTC

COVID-19 Update: USDA, FDA Underscore Current Epidemiologic and Scientific Information Indicating No Transmission of COVID-19 Through Food or Food Packaging – U.S. Food & Drug Administration

Commentary: FDA: COVID-19 Not Transmitted by Food or Packaging – WebMD

 


Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)

23 Feb, 2021 | 01:57h | UTC

Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C) – Open Forum Infectious Diseases

Commentary: Experts at Children’s Hospital of Philadelphia Describe Types of Rashes Associated with MIS-C – Children’s Hospital of Philadelphia

 


Identifying COVID-19 risk through observational studies to inform control measures

23 Feb, 2021 | 02:01h | UTC

Identifying COVID-19 Risk Through Observational Studies to Inform Control Measures – JAMA

 

Commentaries on Twitter

 


Editorial: Prophylactic anticoagulation for patients in hospital with covid-19

23 Feb, 2021 | 01:59h | UTC

Prophylactic anticoagulation for patients in hospital with covid-19 – The BMJ

Related: Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials AND Cohort study: Early initiation of prophylactic anticoagulation linked to reduced mortality in patients admitted to hospital with Covid-19

 


What makes new variants of SARS-CoV-2 concerning is not where they come from, but the mutations they contain

23 Feb, 2021 | 01:56h | UTC

What makes new variants of SARS-CoV-2 concerning is not where they come from, but the mutations they contain – The BMJ Opinion

Related: The world needs a single naming system for coronavirus variants – Nature AND Why the WHO won’t call it the ‘U.K. variant’, and you shouldn’t either – CTV News

 


M-A: Asthma does not increase the risk of infection, hospitalization, ICU admission, and mortality from COVID-19

23 Feb, 2021 | 01:44h | UTC

Asthma and risk of infection, hospitalisation, ICU admission and mortality from COVID-19: Systematic review and meta-analysis – Journal of Asthma

Commentary: Study: Asthma does not increase risk of severe illness or death from COVID-19 – News Medical

See also: COVID vaccine and asthma: why most sufferers won’t be prioritised in the next phase of rollout – The Conversation

 


Can COVID vaccines stop transmission? Scientists race to find answers

23 Feb, 2021 | 01:42h | UTC

Can COVID vaccines stop transmission? Scientists race to find answers – Nature

Related: Fauci: There’s evidence COVID-19 vaccines don’t just protect you — they may stop you from spreading the virus to others, too – Insider AND [Preprint] Covid-19 vaccination associated with reduced viral load, may reduce transmission (study and commentary)

 


Opinion – Is it time to delay second doses of coronavirus vaccines?

21 Feb, 2021 | 22:39h | UTC

Is it time to delay second doses of coronavirus vaccines? – CNN

Related: Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination – New England Journal of Medicine

 


3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval

21 Feb, 2021 | 22:42h | UTC

News Release: 3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval – The Lancet

Original study: Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials – The Lancet

 


Opinion – Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?

21 Feb, 2021 | 22:38h | UTC

Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture? – The Lancet

Related: Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination – New England Journal of Medicine

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.